These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3131074)

  • 21. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.
    Bogdan C; Moll H; Solbach W; Röllinghoff M
    Eur J Immunol; 1990 May; 20(5):1131-5. PubMed ID: 2113475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.
    Bate CA; Taverne J; Román E; Moreno C; Playfair JH
    Immunology; 1992 Jan; 75(1):129-35. PubMed ID: 1537589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.
    Liew FY; Li Y; Millott S
    J Immunol; 1990 Dec; 145(12):4306-10. PubMed ID: 2175327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.
    Cruz LN; Wu Y; Ulrich H; Craig AG; Garcia CR
    Biochim Biophys Acta; 2016 Jul; 1860(7):1489-97. PubMed ID: 27080559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effector mechanisms against asexual erythrocytic stages of Plasmodium.
    Phillips S
    Immunol Lett; 1994 Jul; 41(2-3):109-14. PubMed ID: 8002024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages).
    Ferrante A; Kumaratilake L; Rzepczyk CM; Dayer JM
    Immunol Lett; 1990 Aug; 25(1-3):179-87. PubMed ID: 2126525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.
    Brouckaert PG; Leroux-Roels GG; Guisez Y; Tavernier J; Fiers W
    Int J Cancer; 1986 Nov; 38(5):763-9. PubMed ID: 3095251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Drapier JC; Wietzerbin J; Hibbs JB
    Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels.
    Hemmer CJ; Kern P; Holst FG; Radtke KP; Egbring R; Bierhaus A; Nawroth PP; Dietrich M
    Am J Med; 1991 Jul; 91(1):37-44. PubMed ID: 1858827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM; Porter DA; Huber SC; Cowan RG
    Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules.
    Troye-Blomberg M; Worku S; Tangteerawatana P; Jamshaid R; Söderström K; Elghazali G; Moretta L; Hammarström M; Mincheva-Nilsson L
    Scand J Immunol; 1999 Dec; 50(6):642-50. PubMed ID: 10607313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells.
    Deem RL; Shanahan F; Targan SR
    Clin Exp Immunol; 1991 Jan; 83(1):79-84. PubMed ID: 1899066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
    Bonavida B; Jewett A
    Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF.
    Butcher GA; Clark IA
    Parasitology; 1990 Dec; 101 Pt 3():321-6. PubMed ID: 2092288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.
    Haranaka K; Satomi N; Sakurai A; Haranaka R
    Ciba Found Symp; 1987; 131():140-53. PubMed ID: 3450479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.